{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T23:56:43Z","timestamp":1792281403699,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","award":["OPUS 11 2016\/21\/B\/NZ4\/00128"],"award-info":[{"award-number":["OPUS 11 2016\/21\/B\/NZ4\/00128"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","award":["PRELUDIUM 2018\/29\/N\/NZ7\/00287"],"award-info":[{"award-number":["PRELUDIUM 2018\/29\/N\/NZ7\/00287"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.intimp.2020.106540","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T10:08:45Z","timestamp":1589191725000},"page":"106540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: behavioral and biochemical analyses"],"prefix":"10.1016","volume":"84","author":[{"given":"Klaudia","family":"Kwiatkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Ciapa\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Rojewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wioletta","family":"Makuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Mika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2020.106540_b0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2010.01.002","article-title":"Chemokines, neuronal-glial interactions, and central processing of neuropathic pain","volume":"126","author":"Gao","year":"2010","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2020.106540_b0010","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.pharep.2018.01.006","article-title":"The importance of chemokines in neuropathic pain development and opioid analgesic potency","volume":"70","author":"Kwiatkowski","year":"2018","journal-title":"Pharmacol. Reports"},{"issue":"24","key":"10.1016\/j.intimp.2020.106540_b0015","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1007\/s00018-019-03255-6","article-title":"Dual CCR5\/CCR2 targeting: opportunities for the cure of complex disorders","volume":"76","author":"Fantuzzi","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.intimp.2020.106540_b0020","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/sj.bjp.0707263","article-title":"Chemokines and their receptors as potential targets for the treatment of asthma","volume":"151","author":"Palmqvist","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106540_b0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.pharmtox.48.121806.154841","article-title":"Chemokines and their receptors: drug targets in immunity and inflammation","volume":"48","author":"Viola","year":"2008","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106540_b0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.aat.2013.08.006","article-title":"The immune aspect in neuropathic pain: Role of chemokines","volume":"51","author":"Liou","year":"2013","journal-title":"Acta Anaesthesiol. Taiwanica"},{"issue":"3","key":"10.1016\/j.intimp.2020.106540_b0035","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1471-4159.2010.07121.x","article-title":"Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices","volume":"116","author":"Zhou","year":"2011","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.intimp.2020.106540_b0040","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1177\/1352458515621796","article-title":"RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis","volume":"22","author":"Mori","year":"2016","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.intimp.2020.106540_b0045","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3389\/fimmu.2017.01079","article-title":"CCL5-glutamate cross-talk in astrocyte-neuron communication in multiple sclerosis","volume":"8","author":"Pittaluga","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2020.106540_b0050","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cyto.2019.03.007","article-title":"Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia","volume":"119","author":"Kwiatkowski","year":"2019","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.intimp.2020.106540_b0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpain.2012.09.015","article-title":"Peritoneal administration of Met-RANTES attenuates inflammatory and nociceptive responses in a murine neuropathic pain model","volume":"14","author":"Liou","year":"2013","journal-title":"J. Pain"},{"key":"10.1016\/j.intimp.2020.106540_b0060","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3389\/fimmu.2018.00494","article-title":"Involvement of macrophage inflammatory protein-1 family members in the development of diabetic neuropathy and their contribution to effectiveness of morphine","volume":"9","author":"Rojewska","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106540_b0065","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.pain.2010.02.025","article-title":"Macrophage inflammatory protein-1alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1beta up-regulation","volume":"149","author":"Kiguchi","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.intimp.2020.106540_b0070","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pnpbp.2015.07.005","article-title":"Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats","volume":"64","author":"Kwiatkowski","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.intimp.2020.106540_b0075","doi-asserted-by":"crossref","first-page":"pp","DOI":"10.1007\/s11481-017-9729-6","article-title":"The RS504393 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in Neuropathic Rats","volume":"12","author":"Kwiatkowski","year":"2017","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.intimp.2020.106540_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2016.04.017","article-title":"Direct and indirect pharmacological modulation of CCL2\/CCR2 pathway results in attenuation of neuropathic pain - In vivo and in vitro evidence","volume":"297","author":"Piotrowska","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2020.106540_b0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuropharm.2016.04.024","article-title":"Maraviroc reduces neuropathic pain through polarization of microglia and astroglia \u2013 Evidence from in vivo and in vitro studies","volume":"108","author":"Piotrowska","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2020.106540_b0090","doi-asserted-by":"crossref","unstructured":"E. Van Der Ryst, Maraviroc \u2013 A CCR5 antagonist for the treatment of HIV-1 infection, Front. Immunol., vol. 6. p. 277, 2015, [Online]. Available: https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2015.00277.","DOI":"10.3389\/fimmu.2015.00277"},{"issue":"3","key":"10.1016\/j.intimp.2020.106540_b0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/13543784.2018.1442436","article-title":"Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis","volume":"27","author":"Tacke","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"3","key":"10.1016\/j.intimp.2020.106540_b0100","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.30249","article-title":"Pharmacological inhibition of CCR2\/5 signaling prevents and reverses alcohol-induced liver damage, steatosis, and inflammation in mice","volume":"69","author":"Ambade","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.intimp.2020.106540_b0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.intimp.2020.106540_b0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.intimp.2020.106540_b0115","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1111\/bph.14185","article-title":"Antinociceptive effects of novel histamine H 3 R and H 4 R receptor antagonists and their influence on morphine analgesia of neuropathic pain in the mouse","volume":"3","author":"Popiolek-Barczyk","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2020.106540_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0138583","article-title":"PD98059 influences immune factors and enhances opioid analgesia in model of neuropathy","volume":"10","author":"Rojewska","year":"2015","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.intimp.2020.106540_b0125","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0031-9384(76)90029-9","article-title":"Chronic catheterization of the spinal subarachnoid space","volume":"17","author":"Yaksh","year":"1976","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.intimp.2020.106540_b0130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: A new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2020.106540_b0135","doi-asserted-by":"crossref","unstructured":"P. Chomczynski, N. Sacchi, The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on, Nat. Protoc., vol. 1, no. 2, pp. 581\u2013585, Jul. 2006, [Online]. Available: http:\/\/dx.doi.org\/10.1038\/nprot.2006.83.","DOI":"10.1038\/nprot.2006.83"},{"key":"10.1016\/j.intimp.2020.106540_b0140","doi-asserted-by":"crossref","unstructured":"M.A. Thacker, A.K. Clark, F. Marchand, S.B. McMahon, Pathophysiology of peripheral neuropathic pain: immune cells and molecules, Anesth. Analg., vol. 105, no. 3, 2007, [Online]. Available: https:\/\/journals.lww.com\/anesthesia-analgesia\/Fulltext\/2007\/09000\/Pathophysiology_of_Peripheral_Neuropathic_Pain_.44.aspx.","DOI":"10.1213\/01.ane.0000275190.42912.37"},{"key":"10.1016\/j.intimp.2020.106540_b0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.sjpain.2017.08.002","article-title":"Targeting cytokines for treatment of neuropathic pain","volume":"17","author":"Hung","year":"2017","journal-title":"Scand. J. pain"},{"issue":"4","key":"10.1016\/j.intimp.2020.106540_b0150","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/mi.9.4.7","article-title":"Chemokine signaling and the management of neuropathic pain","volume":"9","author":"White","year":"2009","journal-title":"Mol. Interv."},{"issue":"7","key":"10.1016\/j.intimp.2020.106540_b0155","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm0798-786","article-title":"Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression","volume":"4","author":"Mummidi","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2020.106540_b0160","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fimmu.2018.00557","article-title":"Advances in biomarker-guided therapy for pediatric- and adult-onset neuroinflammatory disorders: targeting chemokines\/cytokines","volume":"9","author":"Pranzatelli","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106540_b0165","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neulet.2011.07.038","article-title":"Involvement of glutamate NMDA and AMPA receptors, glial cells and IL-1\u03b2 in the spinal hyperalgesia evoked by the chemokine CCL2 in mice","volume":"502","author":"Baamonde","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.intimp.2020.106540_b0170","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.intimp.2016.01.016","article-title":"Gene silencing of MCP-1 prevents microglial activation and inflammatory injury after intracerebral hemorrhage","volume":"33","author":"Yang","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2020.106540_b0175","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MAJ.0b013e31826a82ce","article-title":"Spinal MCP-1 contributes to the development of morphine antinociceptive tolerance in rats","volume":"344","author":"Zhao","year":"2012","journal-title":"Am. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2020.106540_b0180","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1471-4159.2006.03746.x","article-title":"Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury","volume":"97","author":"Zhang","year":"2006","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.intimp.2020.106540_b0185","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3171\/2010.12.SPINE10480","article-title":"Spatiotemporal CCR1, CCL3(MIP-1alpha), CXCR4, CXCL12(SDF-1alpha) expression patterns in a rat spinal cord injury model of posttraumatic neuropathic pain","volume":"14","author":"Knerlich-Lukoschus","year":"2011","journal-title":"J. Neurosurg. Spine"},{"issue":"4","key":"10.1016\/j.intimp.2020.106540_b0190","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.4049\/jimmunol.164.4.2120","article-title":"Experimental autoimmune encephalomyelitis on the SJL mouse: effect of \u03b3\u03b4 T cell depletion on chemokine and chemokine receptor expression in the central nervous system","volume":"164","author":"Rajan","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2020.106540_b0195","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jneuroim.2016.05.003","article-title":"Calcitonin gene-related peptide contributes to peripheral nerve injury-induced mechanical hypersensitivity through CCL5 and p38 pathways","volume":"297","author":"Malon","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106540_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115120","article-title":"Spinal NF-kappaB and chemokine ligand 5 expression during spinal glial cell activation in a neuropathic pain model","volume":"10","author":"Yin","year":"2015","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.intimp.2020.106540_b0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/bcpt.12099","article-title":"Involvement of spinal CC chemokine ligand 5 in the development of bone cancer pain in rats","volume":"113","author":"Hang","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106540_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1297-z","article-title":"Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury","volume":"15","author":"Zhou","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.intimp.2020.106540_b0215","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/brain\/aws330","article-title":"Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain","volume":"136","author":"Imai","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2020.106540_b0220","doi-asserted-by":"crossref","unstructured":"Z. Zhang et al., SNPs in inflammatory genes CCL11, CCL4 and MEFV in a fibromyalgia family study PLoS One 13 6 Jun. 2018 e0198625 e198625. 10.1371\/journal.pone.0198625.","DOI":"10.1371\/journal.pone.0198625"},{"issue":"12","key":"10.1016\/j.intimp.2020.106540_b0225","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1097\/j.pain.0000000000001061","article-title":"High levels of cerebrospinal fluid chemokines point to the presence of neuroinflammation in peripheral neuropathic pain: a cross-sectional study of 2 cohorts of patients compared with healthy controls","volume":"158","author":"B\u00e4ckryd","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.intimp.2020.106540_b0230","doi-asserted-by":"crossref","unstructured":"P.G.S. Makker et al., Characterisation of Immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathy, PLoS One 12(1) (2017) e0170814. 10.1371\/journal.pone.0170814.","DOI":"10.1371\/journal.pone.0170814"},{"issue":"117","key":"10.1016\/j.intimp.2020.106540_b0235","first-page":"1","article-title":"Immunohistochemical analysis in the rat central nervous system and peripheral lymph node tissue sections","volume":"2016","author":"Adzemovic","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.intimp.2020.106540_b0240","article-title":"Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness","author":"Mika","year":"2008","journal-title":"Pharmacol. Rep."},{"issue":"12","key":"10.1016\/j.intimp.2020.106540_b0245","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.tins.2005.10.001","article-title":"Glia: novel counter-regulators of opioid analgesia","volume":"28","author":"Watkins","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.intimp.2020.106540_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2014.09.020","article-title":"Involvement of pro- and antinociceptive factors in minocycline analgesia in rat neuropathic pain model","author":"Rojewska","year":"2014","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2020.106540_b0255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pain.2005.02.009","article-title":"Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation","volume":"115","author":"Ledeboer","year":"2005","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.intimp.2020.106540_b0260","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/1440-1681.12316","article-title":"Minocycline can delay the development of morphine tolerance, but cannot reverse existing tolerance in the maintenance period of neuropathic pain in rats","volume":"42","author":"Zhang","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"8","key":"10.1016\/j.intimp.2020.106540_b0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104420","article-title":"Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain","volume":"9","author":"Mika","year":"2014","journal-title":"PLoS ONE"},{"issue":"40","key":"10.1016\/j.intimp.2020.106540_b0270","doi-asserted-by":"crossref","first-page":"31305","DOI":"10.1074\/jbc.M001269200","article-title":"Morphine induces gene expression of CCR5 in human CEMx174 lymphocytes","volume":"275","author":"Miyagi","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2020.106540_b0275","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/excr.2002.5638","article-title":"Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells","volume":"280","author":"Suzuki","year":"2002","journal-title":"Exp. Cell Res."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2020.106540_b0280","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejphar.2003.10.033","article-title":"Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor","volume":"483","author":"Chen","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.intimp.2020.106540_b0285","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1039\/c2ob06801j","article-title":"Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5","volume":"10","author":"Yuan","year":"2012","journal-title":"Org. Biomol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2020.106540_b0290","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pain.2004.08.029","article-title":"Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells","volume":"112","author":"Brack","year":"2004","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.intimp.2020.106540_b0295","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/QAD.0000000000000988","article-title":"A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus","volume":"30","author":"Thompson","year":"2016","journal-title":"AIDS"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920307566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920307566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:41:55Z","timestamp":1762551715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920307566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":59,"alternative-id":["S1567576920307566"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106540","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: behavioral and biochemical analyses","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106540"}}